21796424|t|Effects of obovatol on GSH depleted glia-mediated neurotoxicity and oxidative damage.
21796424|a|Earlier studies indicate that obovatol (OBO), isolated from a medicinal herb Magnolia obovata, has anti-inflammatory and anti-oxidative properties. Depletion of glutathione (GSH) in glial cells with the gamma-glutamylcysteine synthase inhibitor D,L-buthionine-S,R-sulfoximine (BSO) is known to produce oxidative stress which, in turn, induces these cells to secrete inflammatory cytokines and other neurotoxic substances. In the present study, we investigated the ability of OBO to protect SH-SY5Y neuroblastoma cells from this effect. Human microglia, astrocytes and their surrogate THP-1 and U373 cell lines were activated by treatment with BSO. Such treatment depleted their intracellular GSH and increased levels of damage to DNA, lipids and proteins (8-OHdG, lipid peroxide, protein carbonyls and 3-nitrotyrosine), and activated the inflammatory pathways P38 MAP kinase and NFkappaB. These are accompanied by release of proinflammatory factors such as TNFalpha, IL-6 and nitric oxide. Their conditioned media were toxic to SH-SY5Y cells. All these effects were attenuated by pre-treatment with OBO. Prior treatment of SH-SY5Y cells with OBO also attenuated THP-1 or U373 conditioned media neurotoxicity and also reduced oxidative damage produced by treatment with hydrogen peroxide or BSO. Prior treatment with OBO potentiated survival of SH-SY5Y cells exposed to conditioned medium from BSO-treated THP-1, U373 cells, microglia and astrocytes. The data indicate that OBO could be anti-inflammatory, anti-oxidative and neuroprotective, and be an effective agent for inhibiting pathogenesis in neurological diseases such as Alzheimer disease, Parkinson disease and amyotrophic lateral sclerosis in which glial-mediated neuroinflammation and oxidative stress are thought to contribute to disease progression.
21796424	11	19	obovatol	Chemical	MESH:C036795
21796424	23	26	GSH	Chemical	MESH:D005978
21796424	50	63	neurotoxicity	Disease	MESH:D020258
21796424	116	124	obovatol	Chemical	MESH:C036795
21796424	126	129	OBO	Chemical	MESH:C036795
21796424	163	179	Magnolia obovata	Species	349509
21796424	190	202	inflammatory	Disease	MESH:D007249
21796424	247	258	glutathione	Chemical	MESH:D005978
21796424	260	263	GSH	Chemical	MESH:D005978
21796424	331	361	D,L-buthionine-S,R-sulfoximine	Chemical	MESH:D019328
21796424	363	366	BSO	Chemical	MESH:D019328
21796424	452	464	inflammatory	Disease	MESH:D007249
21796424	485	495	neurotoxic	Disease	MESH:D020258
21796424	561	564	OBO	Chemical	MESH:C036795
21796424	576	597	SH-SY5Y neuroblastoma	CellLine	CVCL:0019
21796424	622	627	Human	Species	9606
21796424	670	675	THP-1	CellLine	CVCL:0006
21796424	680	684	U373	CellLine	CVCL:2818
21796424	729	732	BSO	Chemical	MESH:D019328
21796424	778	781	GSH	Chemical	MESH:D005978
21796424	821	827	lipids	Chemical	MESH:D008055
21796424	842	848	8-OHdG	Chemical	MESH:D000080242
21796424	850	864	lipid peroxide	Chemical	MESH:D008054
21796424	888	903	3-nitrotyrosine	Chemical	MESH:C002744
21796424	924	936	inflammatory	Disease	MESH:D007249
21796424	946	960	P38 MAP kinase	Gene	1432
21796424	965	974	NFkappaB.	Gene	4790
21796424	1043	1051	TNFalpha	Gene	7124
21796424	1053	1057	IL-6	Gene	3569
21796424	1062	1074	nitric oxide	Chemical	MESH:D009569
21796424	1114	1121	SH-SY5Y	CellLine	CVCL:0019
21796424	1185	1188	OBO	Chemical	MESH:C036795
21796424	1209	1216	SH-SY5Y	CellLine	CVCL:0019
21796424	1228	1231	OBO	Chemical	MESH:C036795
21796424	1248	1253	THP-1	CellLine	CVCL:0006
21796424	1257	1261	U373	CellLine	CVCL:2818
21796424	1280	1293	neurotoxicity	Disease	MESH:D020258
21796424	1355	1372	hydrogen peroxide	Chemical	MESH:D006861
21796424	1376	1379	BSO	Chemical	MESH:D019328
21796424	1402	1405	OBO	Chemical	MESH:C036795
21796424	1430	1437	SH-SY5Y	CellLine	CVCL:0019
21796424	1479	1482	BSO	Chemical	MESH:D019328
21796424	1491	1496	THP-1	CellLine	CVCL:0006
21796424	1498	1502	U373	CellLine	CVCL:2818
21796424	1559	1562	OBO	Chemical	MESH:C036795
21796424	1577	1589	inflammatory	Disease	MESH:D007249
21796424	1684	1705	neurological diseases	Disease	MESH:D020271
21796424	1714	1731	Alzheimer disease	Disease	MESH:D000544
21796424	1733	1750	Parkinson disease	Disease	MESH:D010300
21796424	1755	1784	amyotrophic lateral sclerosis	Disease	MESH:D000690
21796424	1809	1826	neuroinflammation	Disease	MESH:D000090862
21796424	Negative_Correlation	MESH:C036795	1432
21796424	Negative_Correlation	MESH:C036795	MESH:D000544
21796424	Positive_Correlation	MESH:D019328	1432
21796424	Negative_Correlation	MESH:C036795	MESH:D007249
21796424	Negative_Correlation	MESH:C036795	3569
21796424	Negative_Correlation	MESH:C036795	7124
21796424	Negative_Correlation	MESH:C036795	MESH:D020271
21796424	Negative_Correlation	MESH:D005978	MESH:D019328
21796424	Positive_Correlation	MESH:D000080242	MESH:D019328
21796424	Negative_Correlation	MESH:C036795	MESH:D006861
21796424	Positive_Correlation	MESH:D008055	MESH:D019328
21796424	Positive_Correlation	MESH:C002744	MESH:D019328
21796424	Positive_Correlation	MESH:D008054	MESH:D019328
21796424	Negative_Correlation	MESH:C036795	MESH:D019328
21796424	Negative_Correlation	MESH:C036795	MESH:D010300
21796424	Negative_Correlation	MESH:C036795	MESH:D009569
21796424	Negative_Correlation	MESH:C036795	MESH:D000090862
21796424	Association	MESH:D007249	1432
21796424	Positive_Correlation	MESH:D019328	MESH:D020258
21796424	Association	MESH:C036795	MESH:D005978
21796424	Negative_Correlation	MESH:C036795	MESH:D000690
21796424	Association	MESH:D007249	4790
21796424	Association	MESH:D005978	MESH:D020258
21796424	Negative_Correlation	MESH:C036795	MESH:D020258

